Amines as pharmaceutical agents
US6521650B1 · kind B1 · utility
2Cited by
9References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 2000 |
| Grant date | Feb 18, 2003 |
| Priority date | — |
| Expiry date | Apr 4, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel gamma aminobutyric acids of formula (I) are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal damage. Processes for the preparation and intermediates useful in the preparation are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.